What trading ranges are disclosed for the iRhythm (IRTC) share sales by Abhijit Talwalkar?

Footnotes state weighted-average prices and ranges for grouped trades. Actual sale prices on February 23, 2026 ranged from lows of $145.190, $146.300, and $147.340 to highs of $145.530, $147.200, and $148.130 per share, with detailed breakdowns available on request.

iRhythm director exercises options, sells 5,312 shares

iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported exercising employee stock options for 5,312 shares at $10.710 per share and receiving an equal number of common shares on February 23, 2026.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported exercising employee stock options for 5,312 shares at $10.710 per share and receiving an equal number of common shares on February 23, 2026. He then sold 5,312 common shares in multiple open-market transactions at prices including $143.400, $145.317, $146.951, and $147.616 per share, leaving 20,299 shares of common stock held directly.

All transactions were carried out under a Rule 10b5-1 trading plan established on May 12, 2025. The exercised option was originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments, and has an expiration date of May 23, 2026; the plan covers options expiring in 2026 and 2027.

Insider Trade Summary

Exercise and Sale: 5,312 shares ($717K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider TALWALKAR ABHIJIT Y

Role Director

Sold 5,312 shs ($774K)

Approx. gross sale proceeds $774K

Approx. exercise cost $57K

Approx. pre-tax spread $717K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	5,312	$10.71	$57K
Exercise	Common Stock	5,312	$10.71	$57K
Sale	Common Stock	1,378	$143.40	$198K
Sale	Common Stock	1,725	$145.317	$251K
Sale	Common Stock	572	$146.951	$84K
Sale	Common Stock	1,637	$147.616	$242K

Holdings After Transaction: Employee Stock Option (right to buy) — 5,312 contracts (Direct); Common Stock — 20,299 shares (Direct)

Footnotes (5)

F1. All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.
F2. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $145.190 to a high of $145.530, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.
F3. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $146.300 to a high of $147.200, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.
F4. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $147.340 to a high of $148.130, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.
F5. The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did iRhythm (IRTC) director Abhijit Talwalkar report?

Abhijit Y. Talwalkar reported exercising employee stock options for 5,312 shares at $10.710 and receiving an equal number of common shares, then selling 5,312 common shares in several open-market transactions on February 23, 2026, while retaining 20,299 shares directly.

How many iRhythm (IRTC) shares did Abhijit Talwalkar sell and at what prices?

He sold a total of 5,312 iRhythm common shares in multiple trades. Reported sale prices included $143.400, $145.317, $146.951, and $147.616 per share, with related footnotes describing weighted-average prices and actual trade ranges executed on February 23, 2026.

Was Abhijit Talwalkar’s iRhythm (IRTC) trading done under a Rule 10b5-1 plan?

Yes, all reported transactions were executed pursuant to a Rule 10b5-1 trading plan that Mr. Talwalkar established on May 12, 2025. The plan covers shares subject to options expiring in 2026 and 2027, including the option exercised in this filing.

How many iRhythm (IRTC) shares does Abhijit Talwalkar hold after these transactions?

Following the option exercise and subsequent sales, Mr. Talwalkar directly holds 20,299 shares of iRhythm common stock. This figure reflects his direct ownership immediately after all reported February 23, 2026 transactions were completed under the disclosed trading plan.

What are the key details of the iRhythm (IRTC) stock option exercised by Abhijit Talwalkar?

The option was originally granted on May 23, 2016 for 21,248 shares, vesting in thirty-six equal monthly installments. It carries an exercise price of $10.710 per share and an expiration date of May 23, 2026, and was partially exercised for 5,312 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/24/2026 - 05:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TALWALKAR ABHIJIT Y

(Last)

(First)

(Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO

94103

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/23/2026	02/23/2026	M		5,312⁽¹⁾	A	$10.71	25,611	D
Common Stock	02/23/2026	02/23/2026	S		1,378⁽¹⁾	D	$143.4	24,233	D
Common Stock	02/23/2026	02/23/2026	S		1,725⁽¹⁾	D	$145.317⁽²⁾	22,508	D
Common Stock	02/23/2026	02/23/2026	S		572⁽¹⁾	D	$146.951⁽³⁾	21,936	D
Common Stock	02/23/2026	02/23/2026	S		1,637⁽¹⁾	D	$147.616⁽⁴⁾	20,299	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$10.71	02/23/2026	02/23/2026	M			5,312	06/23/2016	05/23/2026⁽⁵⁾	Common Stock	5,312	$10.71	5,312	D

Explanation of Responses:

1. All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

2. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $145.190 to a high of $145.530, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.

3. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $146.300 to a high of $147.200, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.

4. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on February 23, 2026. The actual sale prices ranged from a low of $147.340 to a high of $148.130, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 3 decimal points.

5. The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

Remarks:

On January 12, 2026, iRhythm Technologies, Inc. (iRhythm Tech) and iRhythm Holdings, Inc. (Issuer) effectuated a holding company reorganization pursuant to which the Issuer became the successor issuer to iRhythm Tech pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended. On such date, all outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one for one basis, with no change to the proportionate interests of security holders.

	/s/ Marc Rosenbaum, attorney-in-fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR